| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2011 | US20110021569 Piperidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/27/2011 | US20110021568 Tubulysin d analogues |
| 01/27/2011 | US20110021567 Preparation of lenalidomide |
| 01/27/2011 | US20110021566 Genetic markers for efficacy of iloperidone in the treatment of psychotic symptoms |
| 01/27/2011 | US20110021565 Piperidine derivatives as nk3 antagonists |
| 01/27/2011 | US20110021564 Method of treating binge eating disorder and obesity resulting from binge eating behavior |
| 01/27/2011 | US20110021563 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| 01/27/2011 | US20110021562 Treatment of friedreich's ataxia using histone deacetylase inhibitors |
| 01/27/2011 | US20110021561 Quinoline compound and pharmaceutical composition, preparation method and uses thereof |
| 01/27/2011 | US20110021560 Compositions And Methods For Regulating Chondrocyte Proliferation In Bone Disorders |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021558 Thieno-pyridine derivatives as mek inhibitors |
| 01/27/2011 | US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives |
| 01/27/2011 | US20110021556 Pyrrolidinyl derivatives and uses thereof |
| 01/27/2011 | US20110021555 Lower dosage strength imiquimod formulations and shorter dosing regimens for treating actinic keratoses |
| 01/27/2011 | US20110021554 Immune response modifier formulations and methods |
| 01/27/2011 | US20110021553 Immunosuppressive macrolide powder for oral suspension |
| 01/27/2011 | US20110021552 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Depression, Anxiety, and Neurodegenerative Disorders |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021550 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | US20110021548 Inhibitors of malt1 proteolytic activity and uses thereof |
| 01/27/2011 | US20110021547 Substantially Pure and a Stable Crystalline Form of Bosentan |
| 01/27/2011 | US20110021546 Gene Defects And Mutant ALK Kinase In Human Solid Tumors |
| 01/27/2011 | US20110021545 Novel preparation for external use |
| 01/27/2011 | US20110021544 Hydrochloride salt of ((1s,2s,4r)-4--2-hydroxycyclopentyl)methyl sulfamate |
| 01/27/2011 | US20110021543 Heterocyclic compounds and their use as pesticides |
| 01/27/2011 | US20110021542 Use of a Combination of Udenafil and Alfuzosin or Oxybutynin for the Treatment of Overactive Bladder |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021538 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| 01/27/2011 | US20110021537 Heterocyclic pyrazole-carboxamidesas p2y12 antagonists |
| 01/27/2011 | US20110021536 Crystalline Forms and Two Solvated Forms of 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one Lactic Acid Salts |
| 01/27/2011 | US20110021535 Trazodone Composition for Once a Day Administration |
| 01/27/2011 | US20110021534 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease |
| 01/27/2011 | US20110021533 Cysteine prodrugs to treat schizophrenia and drug addiction |
| 01/27/2011 | US20110021532 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/27/2011 | US20110021531 Oxazole derivatives useful as inhibitors of faah |
| 01/27/2011 | US20110021530 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders |
| 01/27/2011 | US20110021529 P53 activating compounds |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021527 Dual-acting oxazole antihypertensive agents |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021524 Compositions and methods for treating cancers |
| 01/27/2011 | US20110021523 Aryl sulfonamides |
| 01/27/2011 | US20110021522 Activators of executioner procaspases 3, 6 and 7 |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021520 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021518 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 01/27/2011 | US20110021517 Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents |
| 01/27/2011 | US20110021516 Monocyclic cgrp receptor antagonists |
| 01/27/2011 | US20110021515 Dihyrofuropyrmindine compounds |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021512 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 01/27/2011 | US20110021511 Substituted 5h-pyrimido[5,4-b]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system |
| 01/27/2011 | US20110021510 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 01/27/2011 | US20110021509 Pde10 inhibitors and related compositions and methods |
| 01/27/2011 | US20110021508 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement |
| 01/27/2011 | US20110021507 Inhibiting antipsychotic-induced weight gain |
| 01/27/2011 | US20110021506 Anthelmintic agents and their use |
| 01/27/2011 | US20110021505 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid N-phenylamides in the treatment of pain |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021503 Use and composition for treating dementia |
| 01/27/2011 | US20110021502 Use of cholinesterase inhibitors for treating vascular depression |
| 01/27/2011 | US20110021501 Substituted piperazino-dihydrothienopyrimidines |
| 01/27/2011 | US20110021500 Novel compounds |
| 01/27/2011 | US20110021499 Urethral suppositories for overactive bladder |
| 01/27/2011 | US20110021498 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021496 Thienopyrimidine derivatives as p13k inhibitors |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021494 Novel tetrahydro-fused pyridines as histone deacetylase inhibitors |
| 01/27/2011 | US20110021493 Substituted tricyclic compounds and methods of use thereof |
| 01/27/2011 | US20110021492 Pyridazine derivatives as factor xia inhibitors |
| 01/27/2011 | US20110021491 Compounds, pharmaceutical composition and methods relating thereto |
| 01/27/2011 | US20110021490 Chromene compounds, a process for their preparationand pharmaceutical compositions containing them |
| 01/27/2011 | US20110021489 Substituted piperidines |
| 01/27/2011 | US20110021488 New Compounds |
| 01/27/2011 | US20110021487 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 01/27/2011 | US20110021486 Viral polymerase inhibitors |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021484 Gallium compounds and methods of use to treat inflammatory bowel disease |
| 01/27/2011 | US20110021483 Platinum (IV) Complexes |
| 01/27/2011 | US20110021482 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents |
| 01/27/2011 | US20110021481 Novel Compounds and Methods for Their Production |
| 01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
| 01/27/2011 | US20110021479 Pyrrolopyrimidinecarboxamides |
| 01/27/2011 | US20110021478 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 01/27/2011 | US20110021477 Combinations comprising antimuscarinic agents and corticosteriods |
| 01/27/2011 | US20110021476 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 01/27/2011 | US20110021475 Compositions And Methods for Treatment Of Fibrosis |
| 01/27/2011 | US20110021474 Ecdysterone Compounds |
| 01/27/2011 | US20110021473 Inhibitors of phosphodiesterase type-iv |
| 01/27/2011 | US20110021472 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative, use thereof, and medicament containing the derivative |
| 01/27/2011 | US20110021471 REDUCING Abeta42 LEVELS AND Abeta AGGREGATION |
| 01/27/2011 | US20110021470 Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same |
| 01/27/2011 | US20110021469 baclofen solution for low-volume therapeutic delivery |